1. Search Result
Search Result
Results for "

Bemfivastatin

" in MedChemExpress (MCE) Product Catalog:
Art. -Nr. Produktname Target Forschungsgebiete Chemical Structure
  • HY-106281

    PPD 10558

    HMG-CoA Reductase (HMGCR) Metabolic Disease
    Bemfivastatin (PPD 10558) is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin can be used for research of metabolic disease, such as hypercholesterolemia .
    Bemfivastatin
  • HY-106281A

    PPD 10558 hemicalcium

    HMG-CoA Reductase (HMGCR) Metabolic Disease
    Bemfivastatin (PPD 10558) hemicalcium is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin hemicalcium enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin hemicalcium can be used for research of metabolic disease, such as hypercholesterolemia .
    Bemfivastatin hemicalcium
  • HY-106281R

    PPD 10558 (Standard)

    Reference Standards HMG-CoA Reductase (HMGCR) Metabolic Disease
    Bemfivastatin (Standard) is the analytical standard of Bemfivastatin (HY-106281). This product is intended for research and analytical applications. Bemfivastatin (PPD 10558) is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin can be used for research of metabolic disease, such as hypercholesterolemia .
    Bemfivastatin (Standard)

Online-Anfrage

Your information is safe with us. * Required Fields.

Anrede

 

Country or Region *

Name des Antragstellers *

 

Name der Organisation *

Department *

     

E-Mail-Addresse *

 

Produktname *

Art. -Nr.

 

Requested quantity *

Telefonnummer *

     

Bemerkungen

Online-Anfrage

Inquiry Information

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent: